MedTrace Logo

Detection of Lung Cancer by Plasma Lipids

NCT04287712 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 558

Last updated 2020-06-04

No results posted yet for this study

Summary

There are no reliable blood-based tests currently available for early-stage lung cancer diagnosis. We try to establish a highly accurate method for detecting early-stage lung cancer by combining machine learning with untargeted and targeted metabolomics .

Conditions

Interventions

DIAGNOSTIC_TEST

Plasma lipids

Plasma lipids were detected by an Ultimate 3000 ultra-high-performance liquid chromatography (UHPLC) system coupled with Q-Exactive MS (Thermo Scientific) . Then a detection model was built based on plasma lipids using machine learning algorithm.

Sponsors & Collaborators

  • Beijing Haidian Hospital

    collaborator OTHER

  • Jiangsu Cancer Institute & Hospital

    collaborator OTHER

  • Peking University Health Science Center

    collaborator OTHER

  • Peking University People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-13
Primary Completion
2019-10-31
Completion
2020-05-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04287712 on ClinicalTrials.gov